资讯

pharmaphorum3 天

Boehringer, Lilly’s Jardiance tries to match AZ’s Farxiga with ...

FDA starts fast-track review of Lilly and Boehringer SGLT2 inhibitor Jardiance in heart failure with reduced ejection fraction, chasing AstraZeneca’s rival Farxiga ...